Cancer Care for Lymphoid Leukemias (C91) in Russia: An Epidemiological and Survival Analysis (A Clinico-Population Study). Part I

Vakhtang M. Merabishvili; Svetlana A. Kuleva; Alexey M. Belyaev; Vladimir V. Perelygin

doi:10.17816/phf678337

Pharmacy Formulas ›› 2025, Vol. 7 ›› Issue (1) :26 -41. DOI: 10.17816/phf678337

Biomedical Sciences

research-article

Cancer Care for Lymphoid Leukemias (C91) in Russia: An Epidemiological and Survival Analysis (A Clinico-Population Study). Part I

Author information +

N. N. Petrov National Medical Research Centre of Oncology Ministry of public health of Russian Federation

Saint Petersburg State Pediatric Medical University

North-Western State Medical University named after I.I. Mechnikov

Saint Petersburg State Chemical and Pharmaceutical University of the Ministry of Health of the Russian Federation

Honored Scientist of the Russian Federation, DSc Med., Professor, Head of the Department of Cancer Statistics

DSc Med., Associate Professor, Leading Researcher at the Scientific Department of Innovative Methods of Therapeutic Oncology and Rehabilitation, Head of the Pediatric Oncology Department, Professor of the Educational and Methodological Department N. N. Petrov National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation; Head of the Department of Oncology, Pediatric Oncology and Radiation Therapy at the St. Petersburg State Pediatric Medical University of the Ministry of Health of the Russian Federation; Chief Freelance Pediatric Oncologist at the Committee on Public Health

Dr. Med. Sci., Professor, Honored Doctor of the Russian Federation, Corresponding Member of RAS, Director of the N. N. Petrov National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation; Head of the Department of Oncology, North-Western State Medical University named after I.I. Mechnikov

Dr. Med. Sci., Professor, Honored Doctor of the Russian Federation, Head of the Industrial Ecology Department

Show less

History +

PDF

Abstract

Analysis of lymphoid leukemia incidence in various regions of the world allows for the identification of significant trends and differences, which can be useful for further research and the development of measures for the prevention and treatment of these diseases. According to the International Classification of Diseases (ICD-10), lymphoid leukemias (LL) are classified under category C91, with subcategories 0, 1-9. Chronic lymphocytic leukemia (CLL) – subcategory C91.1 – accounts for the majority of patients in this category, representing approximately 70% of all LL cases, while acute lymphoblastic leukemia (ALL) – subcategory C91.0 – accounts for approximately 25%. Lymphoid leukemias are cancers of the hematopoietic system. The disease develops in the bone marrow, where blood cells are normally renewed in a balanced manner, but when the formation of healthy cells is disrupted, a vast number of immature white blood cells are produced, leading to anemia. Immature lympholeukemic cells enter the bloodstream and lymphatic system, affecting the entire body. Therefore, ALL and CLL are considered systemic malignant diseases. The aim of the study is to investigate the characteristics of LL prevalence among different age groups of the population, the nature of annual mortality rates, and the dynamics of observed and relative one-year and five-year survival rates of LL patients, considering the patients’ sex, histological structure, and place of residence. The conducted study confirmed an increase in the incidence of LL (C91) in the Russian population in absolute numbers and “crude” rates by 6% and 5%, respectively, which mainly increased due to the ongoing aging process of the population. The growth of the standardized incidence rate of LL (C91) over 11 years in the country amounted to 0.69%. Over four five-year observation periods, a significant decrease in the mortality rate of LL (C91) patients in the first year of observation from 21.4% to 16.6%, or 22.43%, and in the fifth year of observation over three periods by 19.61% was established.

Keywords

lymphocytic leukemia (C91) / lymphoid leukemia / acute and chronic lymphoblastic leukemia / international classification of diseases (ICD-10) / population-based cancer registry / malignant neoplasms / annual mortality / histological structure / One-year and five-year patient survival

Cite this article

Download citation ▾

Vakhtang M. Merabishvili, Svetlana A. Kuleva, Alexey M. Belyaev, Vladimir V. Perelygin. Cancer Care for Lymphoid Leukemias (C91) in Russia: An Epidemiological and Survival Analysis (A Clinico-Population Study). Part I. Pharmacy Formulas, 2025, 7(1): 26-41 DOI:10.17816/phf678337

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	International statistic classification of diseases and problems with health (ICD-10) in 3 volumes. WHO. – Zheneva, 1995. –698 p. (in Russ).

[2]	Международная статистическая классификация болезней и проблем, связанных со здоровьем (МКБ-10) в 3 томах. ВОЗ. – Женева, 1995. – 698 с.

[3]	Reference book of comparison of ICD-9 and ICD-10 codes of revisions by class of neoplasms. Second edition updated and expanded / Edited by prof. V. M. Merabishvili. – St. Petersburg, 1997. – 92p. (in Russ).

[4]	Справочник сопоставления кодов МКБ-9 и МКБ-10 пересмотров по классу новообразований. Второе издание уточненное и дополненное / Под ред. проф. В. М. Мерабишвили. – СПб., 1997. – 92 с.

[5]	Inaba H., Greaves M., Mullighan C. G. Acute lymphoblastic leukaemia // Lancet. – 2013. – V. 381, iss. 9881. – P. 1943–55.

[6]	Inaba H., Greaves M., Mullighan C. G. Acute lymphoblastic leukaemia // Lancet. –2013. – V. 381, iss. 9881. – P. 1943–55.

[7]	Greaves M. F. Aetiology of acute leukaemia// Lancet. – 1997. – V. 349, iss. 9048. – P. 344–9.

[8]	Cancer Incidence in Five Continents. Volume XII. Registry Summary tables. https://ci5.iarc.fr/ci5-xii/tables/summary

[9]	Malignant tumors in Russia in 2015 (morbidity and mortality) / Ed. A. D. Kaprina, V. V. Starinskogo, G. V. Petrovoi. – M.: P. A. Herzen MSIOI – filial of NMRC of radiology Ministry of Public Health of the Russian Federation, 2016. – p. 250. (in Russ).

[10]	Злокачественные новообразования в России в 2015 году (заболеваемость и смертность) /Под ред. А. Д. Каприна, В. В. Старинского, Г. В. Петровой. – М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2017. – 250с.

[11]	Malignant tumors in Russia in 2023 (morbidity and mortality) / Ed. Kaprin A. D., Starinsky V. V., Shakhzadova A. O. – M.: P. A. Herzen MSIOI – filial of NMRC of radiology Ministry of Public Health of the Russian Federation, 2024. – 276 p. (in Russ).

[12]	Злокачественные новообразования в России в 2023 году (заболеваемость и смертность) / под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой. М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2024. – илл. – 276 с. ISBN978-5-85502-298-8

[13]	Merabishvili V. M. Covid and cancer in Russia. // Problems in Oncology. 2022; 68(4): 381–92. doi: 10.37469/0507-3758–2022-68-4-381-392. (in Russ).

[14]	Мерабишвили В. М. Коронавирусы и рак в России // Вопросы онкологии. – 2022. – Т. 68, № 4. – С. 381–392. – doi: 10.37469/0507-3758-2022-68-4-381-392.

[15]	Malignant tumors in Russia in 2000 (morbidity and mortality) / Chissov V. I., Starinsky V. V. // Moscow: P. A. Hertsen MNIOI. 2002:264. (in Russ).

[16]	Злокачественные новообразования в России в 2000 году (заболеваемость и смертность) / Под ред. В. И. Чиссова, В. В. Старинского. – М.: МНИОИ им. П. А. Герцена, 2002. – 264 с.

[17]	Malignant neoplasms in Russia in 2005 (morbidity and mortality) / Chissov V. I., Starinsky V. V., Petrova G. V. // Moscow: P. A. Hertsen MNIOI. – 2007. – 252 p. (in Russ).

[18]	Злокачественные новообразования в России в 2005 году (заболеваемость и смертность) / Под ред. В. И. Чиссова, В. В. Старинского, Г. В. Петровой – М.: МНИОИ им. П. А. Герцена, 2007. – 252 с.

[19]	Malignant tumors in Russia in 2010 (morbidity and mortality) / Chissov V. I., Starinsky V. V., Petrova G. V. // Moscow: P. A. Hertsen MNIOI. – 2012. – 260 p. (in Russ).

[20]	Злокачественные новообразования в России в 2010 году (заболеваемость и смертность) / Под ред. В. И. Чиссова, В. В. Старинского, Г. В. Петровой – М.: МНИОИ им. П. А. Герцена, 2012. – 260 с.

[21]	Malignant tumors in Russia in 2019 (morbidity and mortality) / Kaprin A. D., Starinsky V. V., Shakhzadova A. O. // Moscow: P. A. Hertsen MNIOI. – 2020. – 214 p. (in Russ).

[22]	Злокачественные новообразования в России в 2019 году (заболеваемость и смертность) / Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой. – М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2020. – 214 c.

[23]	Malignant tumors in Russia in 2020 (morbidity and mortality) / Kaprin A. D., Starinsky V. V, Shakhzadova A. O. // Moscow: P. A. Hertsen MNIOI. – 2021. – 252p. (in Russ).

[24]	Злокачественные новообразования в России в 2020 году (заболеваемость и смертность) / Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой. – М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2021. – 252 с.

[25]	Malignant tumors in Russia in 2021 (morbidity and mortality) / Kaprin A. D., Starinsky V. V., Shakhzadova A. O. // Moscow: P. A. Hertsen MNIOI. – 2022. – 252p. (in Russ).

[26]	Злокачественные новообразования в России в 2021 году (заболеваемость и смертность) / Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой. – М.: МНИОИ им. П. А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. – 252 с.

[27]	Merabishvili V. M. Oncology statistic (traditional methods, new information technology): manual for physicians. Part I. – SPb.: KOSTA, 2011. – 221 p. (in Russ).

[28]	Мерабишвили В. М. Онкологическая статистика (традиционные методы, новые информационные технологии): руководство для врачей. Часть I. – СПб.: ООО «Издательско-полиграфическая компания «КОСТА», 2011. – 221 с.

[29]	Merabishvili V. M. Oncology statistic (traditional methods, new information technology): manual for physicians. Part II. – SPb.: KOSTA, 2011. – 248 p. (in Russ).

[30]	Мерабишвили В. М. Онкологическая статистика (традиционные методы, новые информационные технологии): руководство для врачей. Часть II. – СПб.: ООО «Издательско-полиграфическая компания «КОСТА», 2011. – 248 с.

[31]	Survival of cancer patients in Europe: The EUROCARE Study (IARC Scientific Publications No. 132). Ed. by F. Berrino et al. Lyon: International Agency for Research on Cancer, 1995.

[32]	Survival of cancer patients in Europe: The EUROCARE-2 study (IARC Scientific Publications No. 151). Ed. by F. Berrino et al. Lyon: International Agency for Research on Cancer, 1999.

[33]	Berrino F., Capocaccia R., Esteve J. et al. EUROCARE-3: The survival of cancer patients diagnosed in Europe during 1990–94. Ann Oncol 2003;14(Suppl 5):1–155.

[34]	Berrino F., Capocaccia R., Esteve J. et al. EUROCARE-3: The survival of cancer patients diagnosed in Europe during 1990–94. Ann Oncol 2003;14(Suppl. 5):1–155.

[35]	Capocaccia R., Gavin A., Hakulinen T. et al. Survival of cancer patients in Europe, 1995–2002. The EUROCARE-4 study. Eur J Cancer 2009;45.

[36]	De Angelis R., Sant M., Coleman M. et al. Cancer survival in Europe 1999–2007 by country and age: Results of EUROCARE-5 – a population-based study. Lancet Oncol 2014;15:23–34. doi: 10.1016/ S1470-2045(13)70546-1

[37]	Merabishvili V. M. Survival of cancer patients. Vol. 2, part I. Sain Petersburg: KOSTA, 2011. 332 p. (In Russ).

[38]	Мерабишвили В. М. Выживаемость онкологических больных. Том 2, часть I. СПб.: КОСТА, 2011. 332 с.

[39]	Merabishvili V. M. Survival of cancer patients. 2nd edn, part II. Ed. By Yu.A. Shcherbuk. Saint Petersburg: KOSTA, 2011. 408 p. (In Russ).

[40]	Мерабишвили В. М. Выживаемость онкологических больных. Выпуск 2, часть II. Под ред. Ю. А. Щербука. СПб.: КОСТА, 2011. 408 с.

[41]	Merabishvili V. M. Malignant neoplasms in the North-Western Federal District of Russia (incidence, mortality, reliability of accounting, patient survival). Express information. Issue 5. Ed. by Prof. A. M. Belyaev, Prof. A. M. Shcherbakov. Saint Petersburg: Izdatelskie tekhnologii, 2020. (In Russ).

[42]	Мерабишвили В. М. Злокачественные новообразования в Северо-Западном федеральном округе России (заболеваемость, смертность, достоверность учета, выживаемость больных). Экспресс-информация. Выпуск 5. Под ред. проф. А. М. Беляева, проф. А. М. Щербакова. СПб.: Издательские технологии, 2020.